275 related articles for article (PubMed ID: 23418787)
21. The phosphatase of regenerating liver-3 protein (PRL-3) promotes glioma cell invasiveness by interacting with β3 -tubulin.
Ge Z; Gu T; Zhang L; Fan Q; Ma L; Fang N
Bioengineered; 2022 Feb; 13(2):4112-4121. PubMed ID: 35098869
[TBL] [Abstract][Full Text] [Related]
22. Effects of metastasis-associated in colon cancer 1 inhibition by small hairpin RNA on ovarian carcinoma OVCAR-3 cells.
Zhang R; Shi H; Chen Z; Wu Q; Ren F; Huang H
J Exp Clin Cancer Res; 2011 Sep; 30(1):83. PubMed ID: 21923915
[TBL] [Abstract][Full Text] [Related]
23. Identification of integrin alpha1 as an interacting protein of protein tyrosine phosphatase PRL-3.
Peng L; Jin G; Wang L; Guo J; Meng L; Shou C
Biochem Biophys Res Commun; 2006 Mar; 342(1):179-83. PubMed ID: 16472776
[TBL] [Abstract][Full Text] [Related]
24. A role for PAX8 in the tumorigenic phenotype of ovarian cancer cells.
Di Palma T; Lucci V; de Cristofaro T; Filippone MG; Zannini M
BMC Cancer; 2014 Apr; 14():292. PubMed ID: 24766781
[TBL] [Abstract][Full Text] [Related]
25. Expression of PRL-3 regulates proliferation and invasion of breast cancer cells in vitro.
Radke I; Götte M; Smollich M; Scharle N; Kiesel L; Wülfing P
Arch Gynecol Obstet; 2017 Dec; 296(6):1153-1160. PubMed ID: 28980126
[TBL] [Abstract][Full Text] [Related]
26. miR-21, miR-17 and miR-19a induced by phosphatase of regenerating liver-3 promote the proliferation and metastasis of colon cancer.
Zhang J; Xiao Z; Lai D; Sun J; He C; Chu Z; Ye H; Chen S; Wang J
Br J Cancer; 2012 Jul; 107(2):352-9. PubMed ID: 22677902
[TBL] [Abstract][Full Text] [Related]
27. WWOX gene expression abolishes ovarian cancer tumorigenicity in vivo and decreases attachment to fibronectin via integrin alpha3.
Gourley C; Paige AJ; Taylor KJ; Ward C; Kuske B; Zhang J; Sun M; Janczar S; Harrison DJ; Muir M; Smyth JF; Gabra H
Cancer Res; 2009 Jun; 69(11):4835-42. PubMed ID: 19458077
[TBL] [Abstract][Full Text] [Related]
28. CNDP2 Acts as an Activator for Human Ovarian Cancer Growth and Metastasis via the PI3K/AKT Pathway.
Zhang LQ; Yang HQ; Yang SQ; Wang Y; Chen XJ; Lu HS; Zhao LP
Technol Cancer Res Treat; 2019 Jan; 18():1533033819874773. PubMed ID: 31537175
[TBL] [Abstract][Full Text] [Related]
29. The phosphatase of regenerating liver-3 (PRL-3) is important for IL-6-mediated survival of myeloma cells.
Slørdahl TS; Abdollahi P; Vandsemb EN; Rampa C; Misund K; Baranowska KA; Westhrin M; Waage A; Rø TB; Børset M
Oncotarget; 2016 May; 7(19):27295-306. PubMed ID: 27036022
[TBL] [Abstract][Full Text] [Related]
30. PRL-3 down-regulates PTEN expression and signals through PI3K to promote epithelial-mesenchymal transition.
Wang H; Quah SY; Dong JM; Manser E; Tang JP; Zeng Q
Cancer Res; 2007 Apr; 67(7):2922-6. PubMed ID: 17409395
[TBL] [Abstract][Full Text] [Related]
31. Proteomic analysis identifies translationally controlled tumor protein as a mediator of phosphatase of regenerating liver-3-promoted proliferation, migration and invasion in human colon cancer cells.
Chu ZH; Liu L; Zheng CX; Lai W; Li SF; Wu H; Zeng YJ; Zhao HY; Guan YF
Chin Med J (Engl); 2011 Nov; 124(22):3778-85. PubMed ID: 22340241
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of phosphatase of regenerating liver-3 expression in ovarian cancer.
Ren T; Jiang B; Xing X; Dong B; Peng L; Meng L; Xu H; Shou C
Pathol Oncol Res; 2009 Dec; 15(4):555-60. PubMed ID: 19247814
[TBL] [Abstract][Full Text] [Related]
33. Phosphatase of regenerating liver 3 (PRL-3) is overexpressed in human prostate cancer tissue and promotes growth and migration.
Vandsemb EN; Bertilsson H; Abdollahi P; Størkersen Ø; Våtsveen TK; Rye MB; Rø TB; Børset M; Slørdahl TS
J Transl Med; 2016 Mar; 14():71. PubMed ID: 26975394
[TBL] [Abstract][Full Text] [Related]
34. Targeting ILK and β4 integrin abrogates the invasive potential of ovarian cancer.
Choi YP; Kim BG; Gao MQ; Kang S; Cho NH
Biochem Biophys Res Commun; 2012 Oct; 427(3):642-8. PubMed ID: 23026047
[TBL] [Abstract][Full Text] [Related]
35. miR-339-5p inhibits migration and invasion in ovarian cancer cell lines by targeting NACC1 and BCL6.
Shan W; Li J; Bai Y; Lu X
Tumour Biol; 2016 Apr; 37(4):5203-11. PubMed ID: 26553360
[TBL] [Abstract][Full Text] [Related]
36. PRL-3 engages the focal adhesion pathway in triple-negative breast cancer cells to alter actin structure and substrate adhesion properties critical for cell migration and invasion.
Gari HH; DeGala GD; Ray R; Lucia MS; Lambert JR
Cancer Lett; 2016 Oct; 380(2):505-512. PubMed ID: 27452906
[TBL] [Abstract][Full Text] [Related]
37. PRL-3 promotes the peritoneal metastasis of gastric cancer through the PI3K/Akt signaling pathway by regulating PTEN.
Xiong J; Li Z; Zhang Y; Li D; Zhang G; Luo X; Jie Z; Liu Y; Cao Y; Le Z; Tan S; Zou W; Gong P; Qiu L; Li Y; Wang H; Chen H
Oncol Rep; 2016 Oct; 36(4):1819-28. PubMed ID: 27572739
[TBL] [Abstract][Full Text] [Related]
38. c-FOS suppresses ovarian cancer progression by changing adhesion.
Oliveira-Ferrer L; Rößler K; Haustein V; Schröder C; Wicklein D; Maltseva D; Khaustova N; Samatov T; Tonevitsky A; Mahner S; Jänicke F; Schumacher U; Milde-Langosch K
Br J Cancer; 2014 Feb; 110(3):753-63. PubMed ID: 24322891
[TBL] [Abstract][Full Text] [Related]
39. Expression and clinical role of protein of regenerating liver (PRL) phosphatases in ovarian carcinoma.
Reich R; Hadar S; Davidson B
Int J Mol Sci; 2011 Feb; 12(2):1133-45. PubMed ID: 21541048
[TBL] [Abstract][Full Text] [Related]
40. LIM domain-containing 2 (LIMD2) promotes the progress of ovarian cancer via the focal adhesion signaling pathway.
Chen L; Qian J; You Q; Ma J
Bioengineered; 2021 Dec; 12(2):10089-10100. PubMed ID: 34724866
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
